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Human diets differ from those of non-human primates. Among few obvious differences, humans consume
more meat than most non-human primates and regularly cook their food. It is hypothesized that a dietary
shift during human evolution has been accompanied by molecular adaptations in metabolic pathways.
Consistent with this notion, comparative studies of gene expression levels in primates have found that the
regulation of genes with metabolic functions tend to evolve rapidly in the human lineage. The metabolic
consequences of these regulatory differences, however, remained unknown. To address this gap, we
performed a comparative study using a combination of gene expression andmetabolomic profiling in livers
from humans, chimpanzees, and rhesus macaques. We show that dietary differences between species have a
strong effect onmetabolic concentrations. In addition, we found that differences inmetabolic concentration
across species are correlated with inter-species differences in the expression of the corresponding enzymes,
which control the same metabolic reaction. We identified a number of metabolic compounds with
lineage-specific profiles, including examples of human-species metabolic differences that may be directly
related to dietary differences.
H
uman diets, whether those of traditional hunter-gatherer societies, subsistence agriculturalists, or modern
industrialized societies, are different from the diets of all non-human primates. This difference can be
understood as a consequence of a series of major dietary shifts in the evolutionary history of the human
lineage, includingmeat scavenging and hunting behavior, the controlled use of fire and cooking, plant and animal
domestication, and most recently, the widespread use of chemical additives1. In contrast to the diets of most
modern human populations, which incorporate many foods including meat but are often starch-based (in
agricultural subsistence societies: 50–70% of total calories from starch2), chimpanzees are predominantly fru-
givorous and ingest relatively little starch and meat compared to humans3. This extreme dietary shift in recent
human history has been proposed as a major driving force of human evolution. For example, the advent of
cooking, which has led to consumption of a higher quality diet, is suggested to underlie a concurrent decrease in
gut size and increase in brain size, and perhaps is also a driver of certain shifts in human social behavior4,5.
Some of the dietary changes during human evolution were likely accompanied by corresponding molecular
adaptations. In particular, one might expect human-specific adaptations in metabolic pathways. One remarkable
example of dietary adaptation accompanied by positive selection on a metabolic pathway is lactase persistence,
the ability of humans to digest lactose as adults6,7. This trait, which is thought to be unique to humans among
mammals, is facilitated by substitutions in regulatory regions near the LCT gene, which encodes the lactase
enzyme thatmetabolizes lactose6,8,9. Adaptive changes in gene regulation, such as the ones described for LCT, have
long been thought to play a major role in human evolution.
Recent comparative studies have found large numbers of differences in gene regulation between primate
species in all tissues examined to date10–14. Interestingly, genes involved in metabolism were found to be enriched
among genes whose regulation may have evolved under positive selection in the human liver (using as back-
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ground for the enrichment analysis the particular set of genes
expressed in the liver in the first place13,14). Moreover, genes involved
inmetabolism are also enriched among genes whose promoters show
evidence for positive selection in humans15. These results suggest an
important role for gene regulatory evolution in dietary andmetabolic
adaptation, and prompt a further investigation of inter-primate gene
expression differences in the context of metabolic differences
between species.
Here, we employed gas chromatography/time-of-flight mass spec-
trometry (GC-TOF MS) to quantify the levels of hundreds of nutri-
ents and metabolic compounds in livers from humans, chimpanzees
(Pan troglodytes), and rhesus macaques (Macaca mulatta), using
samples from six individuals from each species, fromwhich we prev-
iously collected gene expression data (from the same individuals)14.
We compared the liver metabolic profiles of the three species and
obtained a partial view of the effects of inter-species dietary differ-
ences on liver metabolism. Moreover, by considering the metabolic
profiles along with gene expression measurements from the same
samples, we gained insight into the interplay between the regulation
of enzymes and between-species metabolic and dietary differences.
Results
We used GC-TOF MS to measure metabolite concentrations in liver
samples from six human, six chimpanzee, and six rhesus macaque
individuals.We performed three technical replicates for each sample,
for a total of 54 measurements. The identities of all metabolites were
validated through amulti-tiered matching algorithm in our in-house
BinBase database system16 using retention index information in
addition to mass spectral matching, unique ion characteristics, peak
purity, and signal/noise metadata for final metabolite reporting
(Supplementary Methods).
Overall we measured the concentration of 399 metabolites in all
samples, of which 177 were known and had an associated name. This
number of measured metabolites is roughly 20% greater than usually
found in human body fluids17, reflecting the highermetabolic activity
and complexity in liver tissues. After normalization, we performed
quality control by using a principal component analysis and inter-
correlation analysis of the data, and excluded three outlier replicates.
In addition, we regressed out two principal components that repre-
sented non-biological artifacts, such as an apparent batch effect (see
SupplementaryMethods). The complete dataset used in all following
analyses is available in Supplementary Table S1.
Differences in metabolite levels between species. Our main goal
was to identify differences in metabolite concentrations among spe-
cies. To do so, we used a linear mixed-effects model, with a fixed
effect for species, to analyze the normalized comparative metabo-
lomics data (see Methods). Using likelihood-ratio tests within the
framework of the linear model, we identified metabolites with
significant differences in concentration between each pair of
species (FDR , 0.05). We thus classified the concentration of 122,
96, and 29 metabolites as significantly different between human-
chimpanzee, human-rhesus macaque, and chimpanzee-rhesus
macaque, respectively (see Supplementary Fig. S3). Overall, the
concentrations of 129 metabolites differ between human and either
of the other two species, yet show no evidence for differences between
chimpanzee and rhesus macaque. The number of species-specific
changes in metabolite concentration (Supplementary Fig. S2) is
much smaller for chimpanzee (62) and rhesus macaque (36).
In order to characterize further the metabolites that show human-
specific changes in concentration levels, we first focused on metabo-
lites for which names have been identified in the KEGG database
(http://www.kegg.jp18).We defined a human-specificmetabolic pat-
tern as a significant difference in concentration level between human
and both chimpanzee and rhesus macaque (FDR , 0.05), while
showing no evidence for difference between the two non-human
primates (FDR. 0.1). We found 21 metabolites with concentration
levels consistent with this inter-species pattern, which also have a
known name and record in KEGG (shown in Fig. 1).
We expect that a number of the human-specific metabolite con-
centrations are likely the result of modern human-specific diet
(namely, these may reflect environmental effects on metabolic pro-
files). For example, erythritol, which has a significantly higher con-
centration in humans compared to the non-human primates, is sugar
alcohol that is often used as a food sweetener. In addition, glucose,
mono olein (palm oil), and quinic acid (a metabolite obtained from
coffee beans) all have higher concentration in humans, consistent
with their higher abundance in a industrialized agricultural society
human diet.
Other examples may reflect more ancient shifts in diet during
human evolution. For example, salicylic acid, an important plant
hormone19, is found at significantly lower concentration in the
human liver compared with the livers of the non-human primates.
Major dietary sources for salicylic acid include plants and fruits, and
it is especially high in berries, as well as in some herbs and spices. On
the other hand, cereals, meat, fish, poultry, eggs, and dairy products
contain little to no salicylic acid20. This result is therefore consistent
with differences in diet among the three primate species, as well as
with previous observations that serum salicylic acid level is higher in
vegetarians compared to non-vegetarians21.
Inter-species differences in metabolic pathways. Since it is difficult
to make sense of inter-species differences in individual metabolites,
we aggregated the evidence that support human-specific concentra-
tions of compounds in metabolic pathways. To do so, we extracted
pathway information from KEGG and examined the combined
evidence for species-specific changes in the metabolic pathway by
considering the P-values associated with tests for inter-species
differences in individual metabolite concentration (Supplementary
Methods). The pathways showing the strongest evidence for human-
specific metabolic patterns (Supplementary Table S3) include lysine
degradation, arginine and proline metabolism, phenylalanine meta-
bolism, phenylalanine, tyrosine and tryptophan biosynthesis, taurine
and hypotaurine metabolism, cyanoamino acid metabolism, gluta-
thione metabolism, and primary bile acid biosynthesis. It is not
always clear how these pathways may be related to human-specific
diets, but primary bile acid biosynthesis is a metabolic pathway
whose primary function is to facilitate processing of dietary fat.
This result is consistent with a human diet that is richer in meat
and fat compared to the diet of the two non-human primates3.
In order to gain further insight on metabolic interactions among
compounds that show human-specific levels, we used the Ingenuity
pathway analysis tool (http://www.ingenuity.com/) to explore
known interaction networks (Fig. 2). We found an interaction net-
work that involves eleven of the 21 human-specific metabolites, with
four of them (hippuric acid, glycine, AMP, and D-glucose) particip-
ating in the same metabolic reactions. The two most significantly
enriched molecular functions among compounds in this network
include Cell-To-Cell Signaling and Interaction, and Energy
Production (Supplementary Table S4; P, 0.05). The two top canon-
ical pathways enriched among metabolites in the network are Lysine
Degradation and Insulin Receptor Signaling (Supplementary Table
S5; P, 0.01). That some of the metabolites showing human-specific
patterns are involved in the same reactions indicates that the inter-
species pattern we observe may reflect shifts in particular metabolic
phenotypes.
Network-level view of differential concentration in metabolic
reactions. Using metabolic pathway data from KEGG also allows
us to examine changes in metabolite concentration between species
in the context of the large-scale metabolic network. To do so, we
examined the correlation between the number of reactions each
metabolite is involved in, and the extent to which the concen-
www.nature.com/scientificreports
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tration of the metabolite differs between species. As a first step, we
summarized the number of reactions each metabolite is involved in
and plotted the distribution of this quantity across metabolites
(Supplementary Fig. S4). We found that although most metabolites
are involved in fewer (,10) reactions, the distribution has a long tail
as few metabolites are involved in many reactions. We therefore
divided the metabolites into two groups, termed low- and high-
connectivity metabolites, using 20 reactions as the cutoff (this is an
arbitrary cutoff, but using a range of alternative cutoffs did not
qualitatively change the subsequent result; see Supplementary
Methods).
We then compared the distribution of likelihood ratio statistics for
tests of inter-species differences in concentration between the high-
and low-connectivity metabolite groups. We found that metabolites
involved in many reactions are less likely to differ between human
and either chimpanzee or rhesus macaque (Supplementary Fig. S5).
Figure 2 | Interaction network enriched with human-specific metabolites. Shaded nodes indicate metabolites showing a human-specific concentration,
with undashed lines connecting compounds involved in the same metabolic reaction. Orange lines are connecting human-specific metabolites. The
interaction network was generated using the Ingenuity Pathway Analysis (IPA) tool.
Figure 1 | Knownmetabolites with human-specific levels.Metabolite levels (y-axis, log-scale) in human (red), chimpanzee (green), and rhesusmacaque
(black). Error bars represent the 6SE within each species.
www.nature.com/scientificreports
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This result has an intuitive explanation, as metabolites that are
involved in more reactions may be less likely to be affected by per-
turbations in other parts of the network. In principle, this is similar to
the observation that proteins that are involved inmany cellular inter-
actions evolve slower than proteins involved in only few interac-
tions22. Our observations suggest an equivalent hypothesis may be
true considering metabolic compounds; namely, that the concentra-
tion of metabolites is less likely to be different among species when
they are involved in multiple reactions.
Next, we tested whether metabolites that are involved in the same
reactions tend to have similar patterns across species. To examine
this, we first calculated the pairwise correlation of metabolite con-
centrations across individuals within species. We then incorporated
information from KEGG on metabolites that are involved in the
same reaction, and examined the distribution of pairwise correlation
values. We found that, in all three species, there is a significantly
higher correlation between the concentrations of pairs of metabolites
involved in the same reaction compared to metabolites involved in
different reactions (see Fig. 3a–c, Supplementary Methods, Supple-
mentary Fig. S6; permutation P , 6 3 1023). This observation sug-
gests that the rate of many metabolic reactions is tightly regulated
across individuals.
To assess whether there is a similar correlated change in metabo-
lite concentration across species, we focused on metabolites whose
concentration significantly (FDR, 0.05) differs between human and
chimpanzee, and examined the direction of change in concentration
(i.e., which species has a higher level). We found that the concentra-
tions of ,75% of metabolite pairs involved in the same reaction
change in the same direction across species, compared to ,50% of
pairs of metabolite not involved in the same reaction (Fig. 3d; P ,
0.02 by Fisher’s exact test). We observed the same pattern when we
considered metabolite pairs where at least one metabolite shows
significant difference in concentration between species (Supple-
mentary Fig. S7, P 5 0.015). These results suggest a coordinated
inter-species change in the concentration levels of metabolites when
they are involved in the same reaction.
A similar observation has been made considering gene expression
and sequence divergence levels in yeast23. A possible explanation is
that this coordinated shift could be a result of a change in a regulator;
for example, an enzyme that changed its expression between species
could drive a correlated change in concentration levels of the meta-
bolites it controls. In the next section we test this hypothesis using a
combination of metabolomics and gene expression data14.
Enzyme expression and metabolite concentration differences
between species. We combined liver gene expression data from
the same eighteen samples14 with the metabolomics data and the
reaction information from KEGG. We identified 1043 enzymes
and 1629 enzyme-metabolite associations for which we have the
corresponding gene expression and metabolomics data. To exa-
mine the correlation between regulatory and metabolomic changes
we classified metabolites into two groups (either similar or different
across species), based on the evidence that their concentration differs
between human and chimpanzee. We then identified the enzymes
that control reactions involving the metabolites, excluding enzymes
that control reactions in both groups. We then considered the
likelihood ratio tests for differences in gene expression levels
between human and chimpanzee (as defined in Blekhman et al.14)
for the transcripts that encode for the enzymes.
We found that enzymes that control reactions involving metabo-
lites whose concentrations significantly differ between human and
chimpanzee are also more likely to be differentially expressed
between the species (Fig. 4a; t-test P 5 0.065; permutation P 5
0.017). Though the evidence for a connection between inter-species
differences in gene expression levels and the corresponding metabo-
lite concentrations is weak, it is robust.We observed the same pattern
regardless of the cutoff used to classify the concentrations of meta-
bolites as different between humans and chimpanzees (Fig. 4b), and
when we considered the median difference in estimated expression
levels between human and chimpanzee instead of the likelihood ratio
statistic (Supplementary Fig. S8). Moreover, enzymes that control
reactions involving metabolites whose concentrations significantly
differ between human and rhesus macaque are also more likely to be
differentially expressed between the species (though this pattern
holds only for the 25 metabolites with the strongest evidence for
differences in concentration between human and rhesus macaque;
Fig. 4c).
Figure 3 | Metabolites involved in the same reactions change their levels in concert within and between species. Cumulative distribution (y-axis) of
correlation coefficients across individuals (x-axis) for metabolites involved in the same reaction (orange) and different reactions (grey), within humans
(A), chimpanzees (B), and rhesus macaques (C). Below each distribution we show the median pairwise correlation with error bars representing a 95%
confidence interval calculated using bootstrapping (1000 resamplings); the difference in medians is significant in all species (human P 5 6 3 1023,
chimpanzee P5 23 1023, and rhesusmacaque P, 1023, using a permutation test; see SIMaterials andMethods). (D) Proportion ofmetabolite pairs that
change their levels in the same direction in human and chimpanzee, considering pairs where bothmetabolites are differentially concentrated between the
species. The proportion is significantly different betweenmetabolite pairs involved in the same reaction (orange) and different reactions (grey, P 5 0.019
using a one-sided Fisher’s exact test). See Supplementary Fig. S8 for a similar plot considering pairs where at least one of the metabolites is differentially
concentrated between the species. Error bars represent 95% confidence intervals calculated using bootstrap resampling.
www.nature.com/scientificreports
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To provide further support for the connection between inter-
species gene expression differences and changes in metabolite
concentrations we performed an additional analysis in which we
stratified the data by the gene expression profiles. Since the corres-
pondence between enzymes and metabolites is not symmetric, this
analysis complements the previous result (which is based on strati-
fication of the data by the metabolomics profiles; Fig. 4). Using this
complimentary approach we again found that the concentrations of
metabolites associated with enzymes that are differentially expressed
between human and chimpanzee are more likely to differ between
the species (Fig. 5a; permutation P 5 0.026). This observation is
robust with respect to the cutoff used to classify gene expression
differences between the species (Fig. 5b). In fact, with more stringent
cutoffs to classify inter-species gene expression differences we
Figure 4 | Metabolites that are differentially concentrated between species are more likely to be involved in reactions catalyzed by enzymes that are
differentially expressed between species. (A) Cumulative distribution of likelihood ratios (LR) for differential expression (DE, x-axis) for enzymes
associated with differentially concentrated (DC, blue) and non-DC (grey) metabolites. The panel within the plot illustrates the medians of the two
distributions with 95% confidence intervals calculated using bootstrapping (see SIMaterials andMethods). (B,C) The LR of enzymes associated with DC
and non-DC metabolites (y-axis) is plotted for multiple cutoffs defining DC (x-axis) in human compared to chimpanzee (B) and rhesus macaque (C).
www.nature.com/scientificreports
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observed larger differences in the concentrations of the correspond-
ing metabolites. In other words, there is a clear positive correlation
between levels of enzyme differential expression and differences in
the concentration of associated metabolites (Fig. 5B; correlation P,
1024).
Discussion
We described a comparative analysis of metabolic profiles in the
livers of humans, chimpanzees, and rhesus macaques. Our results
point to widespread human-specific shifts in liver metabolite con-
centrations, consistent with recent changes in diet in human
evolution. We found that many of the 21 metabolites showing
human-specific levels are directly related to documented differences
in diets between the species; for example, erythritol, glucose, mono
olein, and quinic acid, which have dietary sources unique to humans,
and have significantly higher levels in the human liver.
We note that while the natural diets of chimpanzees and rhesus
macaques differ, their diets in research colonies, where our samples
were collected, are largely similar, which may have intensified the
human-specific effect we observed. Moreover, environmental effects
that are not diet-related, such as differences in age and sex, may have
had an influence on some of the patterns that we discovered as well.
Although sex has been shown to be correlated with differences in
gene expression between species13, we did not identify a significant
sex effect when including sex as a covariate in our model (see sup-
plementary methods). However, we note that the number of indivi-
duals from each sex is small, and the study may be underpowered to
detect differences between sexes within each species. The gut micro-
biota, which has been associated with several metabolic pheno-
types24, presents another dimension of environmental variability
that may have an effect on liver metabolism and gene expression.
We expect that impact of environmental effects, including diet and
the gut microbiome, on metabolic and gene expression profiles,
would be the focus of follow-up studies. An especially intriguing
direction is the use of computational models that incorporate and
assess the contribution of genetic and environmental factors to
explaining variability in molecular phenotypes.
The technique used to quantify metabolite concentrations in our
study was GC-TOF MS, as this technique yields the largest overview
over metabolites smaller than approximately 500 Da, especially the
diversity of carbohydrates (mono-, di- and trisaccharides), sugar
alcohols, hydroxyl acids (including intermediates of the tricarboxylic
acid cycle), amino acids, aromatics, free fatty acids, and ranges of
miscellaneous compounds such as purines and pyrimidines. While
there is overlap in metabolite coverage with complementary tech-
niques such as liquid chromatography/mass spectrometry, GC-TOF
MS is superior in separating isomeric compounds such as fructose
and glucose and has better command over data processing software
such as mass spectral deconvolution, data processing algorithms25
and mass spectral libraries26. As every other metabolomic technique,
GC-TOFMS is limited in scope; for example, complex lipids such as
phosphatidylcholines or thermodegradable metabolites like ATP
cannot be analyzed this way. Therefore, this technique may not give
a complete picture of the metabolome, and certain metabolites that
have an effect on liver functionmay not be represented in our dataset
due to the limitations of the this technology.
Although very little is known about how metabolic profiles differ
between species in the liver, Fu et al. have recently performed similar
metabolic profiling in the brains of multiple primates, and found a
few metabolites with inter-species differences27. Considering the 38
metabolites that were included in the analysis by Fu et al. as well as
the current study, we found that seven have a human-specific pattern
in the brain and four in the liver (Supplementary Table S6). Of those,
two show a human-specific pattern in both tissues: taurine and oxo-
proline. However, the directionality of the taurine inter-species pat-
tern in liver and brain is not consistent and the overlap in the two
studies is in any case not larger than is expected by chance (Fisher’s
exact test P . 0.3).
Although it is clear that some metabolic differences are due to
changes in diet between species, we also found a significant correla-
tion between changes in metabolite concentrations and inter-species
differences in the expression of the genes corresponding to the rel-
evant metabolic enzymes in the liver. The observation that enzymes
that are differentially expressed are more likely to control reactions
Figure 5 | Higher enzyme differential expression between species predicts a higher level of differential concentration for metabolites involved in the
same reaction. (A) Mean LR (y-axis) for DC between human and chimpanzee in metabolites associated with enzymes that are DE (green) and non-DE
(grey). Error bars correspond to 95% confidence intervals calculated using bootstrapping (see SIMaterials andMethods). (B) The difference between the
means described in A (y-axis) for multiple cutoffs to define enzyme DE (x-axis). The dashed line represents a linear regression of the plotted values
(correlation significance is P 5 1.37 3 1025).
www.nature.com/scientificreports
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that involve differentially concentrated metabolites supports the
notion that difference in gene regulation between species likely have
a functional impact on downstream differences in metabolic path-
ways and processes. At this time, however, we cannot distinguish
between specific changes in gene regulation between species that are
the result of a transient response (e.g., as has been observed in mice
fed different diets28) from those that result from evolutionary differ-
ences in diets. However, we note that among the enzymes that
directly interact with diet-related metabolites in Fig. 1, only one
enzyme (trehalase, which hydrolyses trehalose) is differentially
expressed between species. This supports the notion that the differ-
ential expression patterns we observemay not be a transient response
to immediate dietary differences.
Moreover, a correlation between inter-primate differences in
enzyme expression and metabolite concentration was also observed
in the brain27. This pattern, which is less likely to be a response to
inter-species differences in diet28, is similar to the one observed here
and thus might indicate that a genetic basis for such differences is
likely. In addition, cis-regulatory regions of nutrition-related genes
show strong evidence for positive selection during human evolu-
tion15, providing further support for a role for gene regulatory adap-
tations in facilitating the vast dietary shift in recent human evolution.
In summary, our results suggest an interesting link between
human dietary transitions, metabolite concentrations, and gene reg-
ulatory processes. Since humans and primates are not experimental
models, we cannot distinguish between genetic and purely envir-
onmental effects that underlie inter-species differences in metabolite
concentrations. Nevertheless, our observations are consistent with
previous lines of work suggesting that shifts in diet have had import-
ant consequences during human evolution.
Methods
Primate samples. Liver samples from non-human primates were collected at
necropsy, within four hours of death, by the Yerkes primate center, the Southwest
Foundation for Biomedical Research, and MD Anderson Cancer Center. Additional
primate tissues were given to us byAnne Stone (Arizona State University). In all cases,
non-human primate research was approved by the IACUC at the appropriate
institution, and all experiments were performed in accordance with relevant
guidelines and regulations. We collected liver tissue samples from adult chimpanzees
and rhesus macaques that died of natural causes (such as accidents or fights) or were
euthanized due to an illness unrelated to liver. The human adult liver samples were
collected for us by the National Disease Research Interchange (NDRI), and by the
pathology department at Yale University. The study was exempt from IRB as the
human samples were collected post-mortem and de-identified. Detailed information
about all samples is available in Table S2. Tissue samples were immediately frozen and
maintained at 280C. From each liver sample, we excised three small tissue pieces,
each ,100 mg, from different sections of the original, larger sample. This step was
conducted on dry ice to avoid thawing the samples.
Metabolomics experiment. Detailed description of the methods is available in
Supplementary Methods. Briefly, eighteen liver samples were collected from adult
humans, chimpanzees, and rhesus macaques, with six individuals from each species.
2 mg fresh weight of frozen liver tissues were homogenized using a Retsch ball mill
and subsequently extracted with 1 ml of a carefully degassed 220uC cold
isopropanol/acetonitrile/water mixture (35352, v/v/v) for 5 min at 4uC. After
centrifugation, half of the supernatant was dried and metabolites were derivatized by
methoximation and trimethylsilylation as published previously25. 0.5 ul of sample
was injected into multi-baffled liners and automatic liner exchange for every 10
samples into a Gerstel CIS cold injector at an initial temperature of 50uC (ramped by
12uC sec21 to 250uC) with 25 s splitless time during injection. Chromatography was
performed on anAgilent 6890 gas chromatograph with a Restek 30 m3 0.25 mm i.d.
3 0.25 um Rtx-5Sil MS column with 10 m integrated guard column at a constant
flow of Helium of 1 ml min21 starting at 50uC for 1 min, and then ramped at 20uC
min-1 to 330uC. Electron ionization mass spectra were acquired at 70 eV from m/z
85–500 at 20 spectra s21 for 20 min run times. Chromatogram acquisition, data
handling, automated peak deconvolution, and export of spectra was automatically
performed by the Leco ChromaTOF software (v2.32). Data were further processed
using the algorithms implemented in the open-source BinBase metabolome
database16. Metabolites were identified using the Fiehnlib libraries26 and missing
values were replaced from baseline-subtracted raw data for each individual
compound using the BinBase algorithm. The final dataset used here included 399
metabolites detected in all samples, of which 177 had an associated name, and 153
were also found in the KEGG database.
Statistical analysis. The data were quantile-normalized, and following a principal
component analysis we excluded three outlier measurements, and also corrected
possible technical artifacts. To identify metabolites that are differentially
concentrated between species, the final metabolite data were fitted with a mixed-
effects linear model with fixed effect for species and a random effect for individuals.
We calculated the ratio of likelihoods of this full model to that of a reduced model,
which assumes a similar concentration between each pair of species. We then used
this likelihood ratio to estimate a P-value for differential concentration between
species (Supplementary Methods). We used expression data that we have previously
collected and analyzed for the same samples for which we have metabolomics data14.
All metabolic pathway information was downloaded from the KEGG database18. To
identify pathways enriched among metabolites with a human-specific pattern, we
used the Fisher’s combined P-value across all metabolites in each pathway, as well as
the Ingenuity Pathway Analysis tool (http://www.ingenuity.com/).
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